Trial intelligence / Profile preview

BPC 157 for acute grade II hamstring strain

NCT07437547Phase 2Recruiting

Sponsor
Hudson Biotech
Start
Feb 2026
Primary completion
Feb 2027
Countries
1
01

Overview

A Phase 2 trial of bpc-157 in hamstring muscle strain, sponsored by Hudson Biotech. Started Feb 2026; status: recruiting.

02

Drugs

bpc-157
03

Conditions

hamstring muscle strain

Beyond the preview

Go deeper on NCT07437547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07437547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call